AAP
KURA icon

Arax Advisory Partners’s Kura Oncology KURA Stock Holding History

Arax Advisory Partners’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
31,875
+31,353
+6,006% +$296K ﹤0.01% 1878
2026
Q1 		$4.37K Buy
522
+506
+3,163% +$4.35K ﹤0.01% 2849
2025
Q4 		$166 Sell
16
-44,861
-100% -$471K ﹤0.01% 3750
2025
Q3 		$397K Buy
+44,877
New +$320K 0.01% 993
2024
Q4 		– Sell
-26
Closed -$509 – 2593
2024
Q3 		$509 Hold
26
– – ﹤0.01% 2399
2024
Q2 		$536 Buy
+26
New +$534 ﹤0.01% 2320

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Arax Advisory Partners's KURA Position: Q2 2026 in Review

Arax Advisory Partners increased its Kura Oncology (KURA) stake by 6,006% in Q2 2026, buying an estimated $296K and bringing the position to 31,875 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #1878.

Arax Advisory Partners first reported a position in KURA in Q2 2024 and has held it in 6 quarters since. The position peaked at $397K in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Arax Advisory Partners held 31,875 shares of Kura Oncology worth $350K as of Q2 2026.
  • Arax Advisory Partners bought 31,353 Kura Oncology shares in Q2 2026, an estimated $296K.
  • Kura Oncology made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #1878 holding.
  • Arax Advisory Partners first reported a position in Kura Oncology in Q2 2024 and has held it in 6 quarters since.
  • Arax Advisory Partners's Kura Oncology position peaked at $397K in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.